<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>immune checkpoint inhibitors interactions &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/immune-checkpoint-inhibitors-interactions/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Jan 2026 01:04:10 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>immune checkpoint inhibitors interactions &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>How Concomitant Medications Affect Cancer Immunotherapy Outcomes</title>
		<link>https://bioengineer.org/how-concomitant-medications-affect-cancer-immunotherapy-outcomes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 01:03:44 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cancer immunotherapy outcomes]]></category>
		<category><![CDATA[Cancer Treatment Optimization]]></category>
		<category><![CDATA[concomitant medications in cancer therapy]]></category>
		<category><![CDATA[İçeriğe göre en uygun 5 etiket: **ICI-Concomitant Drug Interactions]]></category>
		<category><![CDATA[immune checkpoint inhibitors interactions]]></category>
		<category><![CDATA[immune-related adverse events]]></category>
		<category><![CDATA[immunomodulatory drug effects]]></category>
		<category><![CDATA[Immunomodulatory Drug Effects** * **Açıklama:** * **ICI-Concomitant Drug Interactions:** Makalenin temel odağı (ICI'ler ve eş zamanlı ilaçlar arasındaki etkileşimler).]]></category>
		<category><![CDATA[Immunotherapy Efficacy Modifiers]]></category>
		<guid isPermaLink="false">https://bioengineer.org/how-concomitant-medications-affect-cancer-immunotherapy-outcomes/</guid>

					<description><![CDATA[The ever-evolving landscape of cancer treatment is witnessing remarkable strides, particularly with the advent of immune checkpoint inhibitors (ICIs). These therapies have revolutionized the way oncologists approach malignancies by unleashing the immune system’s ability to combat tumors. However, a nuanced understanding of the multifaceted interactions between ICIs and other medications prescribed to patients remains a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318650</post-id>	</item>
	</channel>
</rss>
